Evidence map›Paper›PMID 39401194›Full record

ArticlePLOS global public health2024

Factors associated with COVID-19 vaccine hesitancy and uptake among populations in the West department of Haiti.

Martine Etienne-Mesubi, Babatunji Oni, Nancy Rachel Labbe-Coq, Marie Colette Alcide-Jean-Pierre, Delva Lamarre, Darwin Dorestan, Marie-Ange Bien-Aime, Venice Dorce, Cory Freivald, Cowan Angell and 4 more

Abstract read
In one paragraph

Article in PLOS global public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Martine Etienne-MesubiDepartment of Medicine, Georgetown University Medical Center, Center for Global Health Practice & Impact, Washington, DC, United States of America.ORCID https://orcid.org/0009-0000-4645-7864
Babatunji OniDepartment of Medicine, Georgetown University Medical Center, Center for Global Health Practice & Impact, Washington, DC, United States of America.
Nancy Rachel Labbe-CoqDepartment of Medicine, Georgetown University Medical Center, Center for Global Health Practice & Impact, Washington, DC, United States of America.
Marie Colette Alcide-Jean-PierreDepartment of Medicine, Georgetown University Medical Center, Center for Global Health Practice & Impact, Washington, DC, United States of America.
Delva LamarreDepartment of Medicine, Georgetown University Medical Center, Center for Global Health Practice & Impact, Washington, DC, United States of America.
Darwin DorestanDepartment of Medicine, Georgetown University Medical Center, Center for Global Health Practice & Impact, Washington, DC, United States of America.ORCID https://orcid.org/0009-0005-0768-3849
Marie-Ange Bien-AimeDepartment of Medicine, Georgetown University Medical Center, Center for Global Health Practice & Impact, Washington, DC, United States of America.
Venice DorceDepartment of Medicine, Georgetown University Medical Center, Center for Global Health Practice & Impact, Washington, DC, United States of America.
Cory FreivaldDepartment of Medicine, Georgetown University Medical Center, Center for Global Health Practice & Impact, Washington, DC, United States of America.
Cowan AngellDepartment of Medicine, Georgetown University Medical Center, Center for Global Health Practice & Impact, Washington, DC, United States of America.
Yingjie WangDepartment of Medicine, Georgetown University Medical Center, Center for Global Health Practice & Impact, Washington, DC, United States of America.
Jenevieve OpokuDepartment of Medicine, Georgetown University Medical Center, Center for Global Health Practice & Impact, Washington, DC, United States of America.
Bryan ShawDepartment of Medicine, Georgetown University Medical Center, Center for Global Health Practice & Impact, Washington, DC, United States of America.
Deus BaziraDepartment of Medicine, Georgetown University Medical Center, Center for Global Health Practice & Impact, Washington, DC, United States of America.ORCID https://orcid.org/0000-0002-6459-5555

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe COVID-19 pandemic in Haiti led to increased challenges for a population concurrently dealing with natural and social disasters, poor quality health care, lack of clean running water, and inadequate housing. In 2022, the population of Haiti was 11.4 million. While half a million vaccines for COVID-19 were donated by the United States to the government of Haiti, less than 5% of the population agreed to be vaccinated. This resulted in thousands of unused doses that were diverted to other countries. The purpose of this study was to evaluate population characteristics related to vaccine uptake in order to inform future interventions to improve COVID-19 vaccine uptake as well as inform strategies to safeguard against future global health security threats.

methodsThis was a mixed-methods, cross-sectional study conducted in the West Department of Haiti within peri-urban communes. Participants consisted of adults in this setting responding to a survey from June 15 to July 18, 2022. The survey assessed demographic information, household characteristics, religious beliefs, past vaccine use, and current COVID-19 vaccine status. Multivariate regression modeling was conducted to assess predictors of vaccine hesitancy. Qualitative focus group discussion participants were recruited and focus group discussions were conducted between August-September 2022 among community groups, religious leaders and health professionals to provide additional, community-level context on perceptions of the COVID-19 pandemic and vaccines.

resultsA total of 1,923 respondents completed the survey; of which a majority were male (52.7%), between the age of 18-35 (58.5%), had a medical visit within the last year (63.0%) and received the COVID-19 vaccine (46.1%). Compared to those who had been COVID-19 vaccinated, participants who had not been vaccinated were more likely to be male (57.7% vs 46.8%, p < .0001), have completed secondary education (30.5% vs 16.6%, p < .001), unemployed (20.3% vs 7.3%, p < .0001) and had a medical visit 3 or more years ago (30.2% vs 11.2%, p < .0001). Unvaccinated COVID-19 participants were also more likely to have never received any other vaccine (36.1% vs22.5%, p < .0001), have a religious leader speak out against the vaccine (20.0% vs 13.1%, p < .0001), not believe in the effectiveness of the vaccine (51.2% vs 9.1%, p < .0001) and did not trust the healthcare worker administering the vaccine (35.2% vs 3.8%, p<0.0001).

conclusionThese results show that targeted interventions to religious leaders and health care workers on how to engage with the community and share clearer messages around the COVID-19 vaccination may result in increased vaccine uptake. Results also shed light on how activities surrounding vaccinations can be tailored to meet client needs addressing the misinformation encountered to achieve greater health impact thereby safeguarding the population against future global health security threats.

Identifiers

PMID39401194
PMCPMC11472929

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.